MELBOURNE
Northlane's album campaign changed shape on Wednesday. Chaoszine reported on October 21 that the Australian metalcore band have delayed the release of their upcoming seventh studio album, Anemoia, and rescheduled their Australian and New Zealand headline tour — while softening the blow with a new single, 'Deathwish,' released ahead of schedule. The album was originally due October 30; it will now arrive November 27, 2026. The tour moves much further: headline dates across Australia and New Zealand that were planned for November 2026 will now take place in May 2027.
The band's own statement, quoted in full by Chaoszine, is unusually direct about the reasons, and there are two of them. The first is practical: 'Due to production delays, the release of Anemoia is moving to November 27, 2026.' The second is personal, and more serious. 'Alongside the album delay, Josh has been dealing with significant, rapidly worsening chronic health issues over the past two years and now requires immediate intervention which will prevent him from travelling or performing,' the band wrote. 'With his health and rehabilitation a priority, alongside the delayed release of the record, we have made the difficult decision to reschedule our Australia & New Zealand tour to May 2027.'
For ticket holders, the mechanics are the standard mercy: all existing tickets remain valid for the rescheduled May 2027 dates, which the band say they will announce very soon. One event actually moves earlier in fans' favor — the Melbourne listening party shifts to November 20, and the band noted that attendees will now be the first in the world to hear Anemoia in full, a week before the delayed release date, with all tickets still valid. The band did not dress any of it up: 'These decisions have been incredibly tough to make. Delivering the full experience to you matters to us, and we don't take decisions like this lightly. We recognise the impact these changes may have on those who've made plans around the original dates, and we appreciate your patience and understanding.'
Just as important is what is not moving. The statement is explicit that the band's UK and European tour with Dayseeker later this year, and their North American headline tour early next year, will both go ahead as planned. That distinction turns a worrying announcement into a bounded one: this is a production delay plus a health-driven pause on one leg, not a band in crisis. Fans in Wolverhampton, Leeds, Manchester, London, Paris and Berlin keep their dates; fans in Sacramento, Anaheim, Dallas, New York, Toronto, Chicago and Vancouver keep theirs too.
'Deathwish' is the gesture that carries the day. The band released the new single ahead of schedule 'as a thank you for your continued support,' and it is available to stream and watch now. It is the fourth preview of Anemoia, following the previously released singles 'Evian,' 'CUT_it' and 'Crucified' — which means that by the time the album finally lands on November 27, fans will already know a substantial stretch of it. Delay announcements usually ask audiences to simply wait; Northlane have instead handed them the next piece of the record and moved the listening party in front of the release. As damage control goes, it is the generous version.
The album being protected this carefully has a clear identity. Anemoia is the follow-up to 2022's Obsidian and will be Northlane's seventh full-length record. As Chaoszine summarized the band's own description, it explores the feeling of nostalgia for a time or place a person has never experienced — anemoia is precisely that word — pairing their heavy sound with electronic and trance influences. That combination has been the band's signature tension for years: metalcore weight wired into club-music machinery, songs that hit like riffs and pulse like synths. A record about longing for somewhere you have never been is a fitting concept for a band whose music has always sounded like it was reaching for a place just out of frame.
There is a human arithmetic underneath the scheduling that the statement, to its credit, does not hide. A member has been managing worsening chronic health problems for two years — through writing, recording and announcing an album — and has reached the point where intervention cannot wait for a tour cycle. Moving a home-region headline run by six months is expensive, disruptive and reputationally awkward, and the band chose it anyway, in public, with the reason named. Audiences tend to remember which bands treated them honestly when plans broke; the flood of patience this announcement will likely receive is the return on that honesty.
The revised calendar is now simple. 'Deathwish' is out today. The Melbourne listening party happens November 20, the album arrives November 27, the UK/EU run with Dayseeker proceeds this winter, North America gets its headline tour early next year, and Australia and New Zealand — the band's home crowd, the audience this record most belongs to — get their shows in May 2027, with the new dates to be announced soon and every existing ticket honored. It is a longer wait than anyone planned. It is also, on the evidence of the statement, the wait the band needed. Follow the heavy-music lane on our news front and browse the Music catalog for more album news.
